Anticoagulants may prolong lives of prostate cancer patients

02/22/2013 | HealthDay News

Researchers tracked nearly 250 patients with advanced or spreading prostate cancer and found a 39% increase in survival among those treated with anticoagulants. Because of bleeding risks, the drugs should be used carefully, experts cautioned. The study examined patients being treated with chemotherapy and was reported at a meeting of the American Society of Clinical Oncology.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ